Search research articles
Contact Us
Filters
Showing results (51-60 of 64) with videos related to
Page
of 7
Sort By:
Current Biology : CB
|
May 11, 2023
Microglia modulate general anesthesia through P2Y<sub>12</sub> receptor
Kelei Cao, Liyao Qiu, Xuan Lu, et al.
Frontiers in Medicine
|
October 29, 2021
Efficacy of Jinhua Qinggan Granules Combined With Western Medicine in the Treatment of Confirmed and Suspected COVID-19: A Randomized Controlled Trial
XueDong An, Xi Xu, MingZhong Xiao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 9, 2014
miR-204-5p inhibits proliferation and invasion and enhances chemotherapeutic sensitivity of colorectal cancer cells by downregulating RAB22A
Yuan Yin, Binbin Zhang, Weili Wang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
July 17, 2022
SHF Acts as a Novel Tumor Suppressor in Glioblastoma Multiforme by Disrupting STAT3 Dimerization
Jingjing Wang, Zixuan Huang, Li Ji, et al.
Journal of the American Medical Directors Association
|
September 3, 2023
Associations of Various Physical Activities with Mortality and Life Expectancy are Mediated by Telomere Length
Huan-Huan Zhou, Biyu Jin, Yuxiao Liao, et al.
Clinical and Translational Medicine
|
September 18, 2022
The positive regulatory loop of TCF4N/p65 promotes glioblastoma tumourigenesis and chemosensitivity
Yaling Hu, Bo Zhang, Peihua Lu, et al.
The Lancet. Infectious Diseases
|
November 20, 2020
Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18-59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial
Yanjun Zhang, Gang Zeng, Hongxing Pan, et al.
Vaccine
|
October 8, 2021
A phase III, observer-blind, randomized, placebo-controlled study of the efficacy, safety, and immunogenicity of SARS-CoV-2 inactivated vaccine in healthy adults aged 18-59 years: An interim analysis in Indonesia
Eddy Fadlyana, Kusnandi Rusmil, Rodman Tarigan, et al.
Nature Communications
|
November 23, 2024
Lysosomal "TRAP": a neotype modality for clearance of viruses and variants
Chengliang Lyu, Zhanlong He, Xiaoming Hu, et al.
Nature
|
December 13, 2023
Inhaled SARS-CoV-2 vaccine for single-dose dry powder aerosol immunization
Tong Ye, Zhouguang Jiao, Xin Li, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 64) with videos related to
Sort By:
Page
of 7
Current Biology : CB
|
May 11, 2023
Microglia modulate general anesthesia through P2Y<sub>12</sub> receptor
Kelei Cao, Liyao Qiu, Xuan Lu, et al.
Frontiers in Medicine
|
October 29, 2021
Efficacy of Jinhua Qinggan Granules Combined With Western Medicine in the Treatment of Confirmed and Suspected COVID-19: A Randomized Controlled Trial
XueDong An, Xi Xu, MingZhong Xiao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 9, 2014
miR-204-5p inhibits proliferation and invasion and enhances chemotherapeutic sensitivity of colorectal cancer cells by downregulating RAB22A
Yuan Yin, Binbin Zhang, Weili Wang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
July 17, 2022
SHF Acts as a Novel Tumor Suppressor in Glioblastoma Multiforme by Disrupting STAT3 Dimerization
Jingjing Wang, Zixuan Huang, Li Ji, et al.
Journal of the American Medical Directors Association
|
September 3, 2023
Associations of Various Physical Activities with Mortality and Life Expectancy are Mediated by Telomere Length
Huan-Huan Zhou, Biyu Jin, Yuxiao Liao, et al.
Clinical and Translational Medicine
|
September 18, 2022
The positive regulatory loop of TCF4N/p65 promotes glioblastoma tumourigenesis and chemosensitivity
Yaling Hu, Bo Zhang, Peihua Lu, et al.
The Lancet. Infectious Diseases
|
November 20, 2020
Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18-59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial
Yanjun Zhang, Gang Zeng, Hongxing Pan, et al.
Vaccine
|
October 8, 2021
A phase III, observer-blind, randomized, placebo-controlled study of the efficacy, safety, and immunogenicity of SARS-CoV-2 inactivated vaccine in healthy adults aged 18-59 years: An interim analysis in Indonesia
Eddy Fadlyana, Kusnandi Rusmil, Rodman Tarigan, et al.
Nature Communications
|
November 23, 2024
Lysosomal "TRAP": a neotype modality for clearance of viruses and variants
Chengliang Lyu, Zhanlong He, Xiaoming Hu, et al.
Nature
|
December 13, 2023
Inhaled SARS-CoV-2 vaccine for single-dose dry powder aerosol immunization
Tong Ye, Zhouguang Jiao, Xin Li, et al.
Page
of 7